key: cord-0783710-iwzo0ugk
authors: Pereira, Daniella Nunes; Silveira, Leticia Ferreira Gontijo; Guimarães, Milena Maria Moreira; Polanczyk, Carísi Anne; Nunes, Aline Gabrielle Sousa; Costa, André Soares de Moura; Farace, Barbara Lopes; Cimini, Christiane Corrêa Rodrigues; de Carvalho, Cíntia Alcantara; Ponce, Daniela; Roesch, Eliane Würdig; Manenti, Euler Roberto Fernandes; Lucas, Fernanda Barbosa; Rodrigues, Fernanda d'Athayde; Anschau, Fernando; Aranha, Fernando Graça; Bartolazzi, Frederico; Vietta, Giovanna Grunewald; Nascimento, Guilherme Fagundes; Duani, Helena; Vianna, Heloisa Reniers; Guimarães, Henrique Cerqueira; Costa, Jamille Hemétrio Salles Martins; Batista, Joanna d'Arc Lyra; de Alvarenga, Joice Coutinho; Chatkin, José Miguel; de Morais, Júlia Drumond Parreiras; Machado-Rugolo, Juliana; Ruschel, Karen Brasil; Pinheiro, Lílian Santos; Menezes, Luanna Silva Monteiro; Couto, Luciana Siuves Ferreira; Kopittke, Luciane; de Castro, Luís César; Nasi, Luiz Antônio; Cabral, Máderson Alvares de Souza; Floriani, Maiara Anschau; Souza, Maíra Dias; Carneiro, Marcelo; Bicalho, Maria Aparecida Camargos; de Godoy, Mariana Frizzo; Nogueira, Matheus Carvalho Alves; Júnior, Milton Henriques Guimarães; Sampaio, Natália da Cunha Severino; de Oliveira, Neimy Ramos; Assaf, Pedro Ledic; Finger, Renan Goulart; Campos, Roberta Xavier; Menezes, Rochele Mosmann; Francisco, Saionara Cristina; Alvarenga, Samuel Penchel; Guimarães, Silvana Mangeon Mereilles; Araújo, Silvia Ferreira; Oliveira, Talita Fischer; Diniz, Thulio Henrique Oliveira; Ramires, Yuri Carlotto; Cenci, Evelin Paola de Almeida; de Oliveira, Thainara Conceição; Schwarzbold, Alexandre Vargas; Ziegelmann, Patricia Klarmann; Pozza, Roberta; Carvalho, Caroline Scherer; Pires, Magda Carvalho; Marcolino, Milena Soriano
title: Hypothyroidism does not lead to worse prognosis in COVID-19: findings from the Brazilian COVID-19 registry
date: 2022-01-19
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2022.01.016
sha: 2712f638d2346ce2e4c93e332771107b5416b8b4
doc_id: 783710
cord_uid: iwzo0ugk

Background It is not clear whether previous thyroid diseases influence the course and outcomes of COVID-19. Methods The study is a part of a multicentric cohort of patients with confirmed COVID-19 diagnosis from 37 hospitals. Matching for age, sex, number of comorbidities and hospital was performed for the paired analysis. Results From 7,762 COVID-19 patients, 526 had previously diagnosed hypothyroidism and 526 were matched controls. The median age was 70 years-old and 68.3% were females. The prevalence of comorbidities was similar, except for coronary and chronic kidney diseases that were higher in the hypothyroidism group (p=0.015 and p=0.001). D-dimer levels were lower in hypothyroid patients (p=0.037). In-hospital management was similar, but hospital length-of-stay (p=0.029) and mechanical ventilation requirement (p=0.006) were lower for patients with hypothyroidism. There was a trend of lower in-hospital mortality in patients with hypothyroidism (22.1% vs. 27.0%; p=0.062). Conclusion Patients with hypothyroidism had a lower requirement of mechanical ventilation, and showed a trend of lower in-hospital mortality. Therefore, hypothyroidism does not seem to be associated with a worse prognosis.

Other studies have found that previous diagnosis of hypothyroidism or other thyroid diseases were not a risk factor for COVID-19 infection and were not associated with poorer outcomes of the disease (Martins JRM, 2021; van Gerwen M, 2020; Shabrawishi M, 2020; Daraei M, 2020) . It is well known that critically ill patients with no previous history of thyroid dysfunction usually present alterations in thyroid hormone levels, a situation known as non-thyroidal illness syndrome (NTIS) (Fliers E, 2015) . Patients with NTIS typically present with decreased concentrations of plasma triiodothyronine (T3), low thyroxine (T4), and usually slightly decreased thyroid-stimulating hormone (TSH), which may be variable depending on the phase of the disease (Fliers E, 2015) . In intensive care units (ICU), patients with conditions such as sepsis, major trauma or burn, and cardiac surgery, among others, NTIS has been associated with disease severity and mortality, without cause-effect association. Rather, NTIS is more likely to be seen as an adaptive mechanism to critical illnesses (Martins JRM, 2021; Fliers E, 2015; Kim, S.-Y., 2021) . As we could expect, NTIS has been frequently observed in COVID-19 patients, with the same pattern as in other critical conditions (British Columbia Ministry of Health, 2018; Beltrão FEL, 2021; Gao W, 2021) .

Literature regarding the association between COVID-19 and previous hypothyroidism is still controversial, results may be biased by the inclusion of NTIS patients, and more studies with larger sample sizes and comparison with non-hypothyroidism patients are still needed. This study aims to compare the evolution of COVID-19 in patients with previous diagnosis of underlying hypothyroidism to patients without the disease, in order to understand if hypothyroidism is an independent risk-factor in the course of COVID-19.

This study is a part of the multicentric cohort study Brazilian COVID-19 Registry.

Consecutive patients with confirmed COVID-19 by RT-PCR or serological tests (IgM) (Marcolino MS, 2021b; World Health Organization, 2020) , admitted to the 37 participant hospitals from March 1st to September 31st, 2020 were eligible (Marcolino MS, 2021b) .

Patients were admitted from March 1st to September 31st, 2020.

For the present analysis, "cases" were patients with a clinical history of previously diagnosed hypothyroidism, on levothyroxine replacement therapy. From 7,762 patients with confirmed COVID-19 diagnosis, 555 (7.15%) had underlying hypothyroidism. Of those, 21

were excluded due to hospital admission for other reasons (not COVID-19), 3 were excluded due to pregnancy and 5 were transferred to other hospitals, with 526 hypothyroid patients remaining eligible for the study ( Figure 1 ). (Barreto PA, 2012) . Individual informed consent was waived due to the pandemic and to the fact that all data collected was unidentified, gathered through medical records.

Data was collected through the analysis of medical records by trained health professionals or undergraduate students (from Medical and Nursing schools) using Research Data Capture (REDCap) tools (Harris PA, 2019) . In the medical records, data collected concerned demographic and clinical characteristics, comorbidities, medication in use prior to admission, COVID-19 symptoms, clinical evaluation at admission, laboratory and radiological exams, medication used during hospitalization and outcomes. Study protocol and definitions were published elsewhere (Marcolino MS, 2021b) .

Statistical analysis was performed using R software (version 4.0.2). To adjust for potential confounding variables, patients who had underlying hypothyroidism were matched to patients who had not underlying hypothyroidism (controls) on the basis of propensity score. Propensity score model was estimated by logistic regression, and included gender, age, number of comorbidities (hypertension, diabetes mellitus, obesity, coronary artery disease, heart failure, atrial fibrillation or flutter, cirrhosis, chronic obstructive pulmonary disease, cancer and previous stroke) (Marcolino MS, 2021b) and hospital. Patients from the control group were searched to find those who had the closest propensity score from the hypothyroidism group (within 0.17 standard deviations of the logit of the propensity score, on a scale from 0-1.00), using the MatchIt package in R software.

Categorical data were presented as absolute frequency and proportions, and continuous variables were expressed as medians and interquartile ranges. The Chi-Square and Fisher Exact tests were used to compare the distribution of categorical variables, and the Wilcoxon-Mann-Whitney test for continuous variables. Results were considered statistically significant if the two-tailed P-value was < 0.05.

The Laboratory exams and biomarkers were similar between groups, except for D-dimer, which was lower in patients with hypothyroidism than the controls (Table 3 ). [insert Table 3] As for medications used during hospitalization, hypothyroidism patients had a lower frequency of inotropes requirement than the control group (24.3% vs. 29.8%, p =0.044). The other medications were similar between groups (Table S1 ).

With regards to patient outcomes, the median hospital length of stay (8 vs Underlying individual comorbidities were similar between groups, except for chronic kidney disease and coronary artery disease. There has been a great interest in the relationship between thyroid dysfunction and kidney function in recent years (Iglesias P, 2017; Narasaki Y, 2021) . Thyroid hormones have shown to directly affect the kidneys, influencing renal growth and development, glomerular filtration rate, renal transport systems, as well as sodium and water homeostasis. An indirect effect through modifications in cardiac and vascular function and disruptions in the renin-angiotensin system is also believed to play an important role in reducing glomerular filtration rate through impaired renal autoregulation. At the same time, patients with autoimmune thyroid disorders are also at risk for immunemediated glomerular diseases (Narasaki Y, 2021) .

As for the higher prevalence of coronary artery disease, the association between hypothyroidism and increased cardiovascular risk is controversial when thyroid-stimulating hormone (TSH) is normal (Decandia F, 2018 within the reference values with the use of hormonal replacement therapy (Sue LY, 2020) .

Another hypothesis to explain the higher frequency of coronary artery disease is the higher prevalence of chronic kidney disease, which is associated with increased cardiovascular risk.

There was no difference in frequency and severity of COVID-19 symptoms between groups, including anosmia and ageusia. Despite the previous evidence of an effect of hypothyroidism at gustatory and olfactory perceptual pathways, including receptors, central olfactory and gustatory areas, and high order cognitive systems, previous cohorts studies did not observe a higher frequency of gustatory or olfactory COVID-19 symptoms in these patients. However, a case series has observed an independent association between hypothyroidism and a higher likelihood of persistent olfactory dysfunction among patients with COVID-19 (OR: 21.1; 95% CI: 2.0 to 219.4) (Tsivgoulis G, 2021) . Further studies are needed to investigate whether hypothyroidism is indeed associated with a higher risk of persistent symptoms.

Overall, laboratorial exams were similar between groups, except for D-dimer levels, which were slightly higher in the control group when compared to patients with hypothyroidism. However, the values were assessed as the number of times above the upper limit of normal, and the difference is not clinically relevant. These findings are different from a study from Wuhan, China, in the early phase of the pandemic, which observed that patients with thyroid dysfunction had persistently high levels of biomarkers for inflammatory response and cardiac injury. However, authors defined thyroid dysfunction by abnormal thyroid function test results within three days from admission, and not previous underlying diseases (Zhang Y, 2020).

Current data shows that COVID-19 is associated with a broad spectrum of thyroid dysfunction, ranging from thyrotoxicosis to NTIS and hypothyroidism, that may worsen disease course and affect prognosis (Ruggeri RM, 2021; Zou R, 2020; Malik J, 2021; Schwarz Y, 2021; Baldelli R, 2021) . This was observed even in mild to moderate COVID-19

cases, independently of SARS-CoV-2 viral load, age and inflammation and tissue injury markers (Lui DTW, 2021a) . The cytokine storm and the dysregulated inflammation are believed to affect the thyroid gland, through the proinflammatory cytokines, which resembles the immune activation that occurs in immune-mediated thyroid diseases, causing damage and compromising function (Ruggeri RM, 2021) . It is also possible that thyroid abnormalities are caused by a direct effect of the virus, leading to subacute thyroiditis, a self-limiting destructive thyroiditis, or affecting angiotensin-converting enzyme 2 (ACE2) receptors thyroid follicular cells, leading to a thyroid malfunction (Ruggeri RM, 2021; Chakraborty U, 2020) . Other contributing factors may be the oxidative stress due to augmented reactive oxygen species generation, which are associated with NTIS, and changes in the intracellular redox state, that may disrupt deiodinase function by independent mechanisms, which might include depletion of the-as yet unidentified-endogenous thiol cofactor (Wajner SM, 2012) .

Nevertheless, there is no evidence that the administration of thyroid hormones improves prognosis in those patients. We might also wonder that, in some studies that observed a correlation between thyroid dysfunction and more severe COVID-19 presentation, the alterations in thyroid hormone levels were actually due to NTIS, as opposed to an underlying previous clinical thyroid disease (Bakshi SS, 2021) . So, these results have to be carefully analysed.

Our findings suggest that underlying hypothyroidism does not lead to worse outcomes in patients with COVID-19. In fact, those patients presented indicators of better outcomes than patients without hypothyroidism. At hospital admission, respiratory rates over 24 breaths per minute were less frequent in hypothyroidism patients than in the control group (36.1% vs 42.0%; p=0.050). It is known that tachypnea is one of the alarming COVID-19 symptoms as it may be an indicator of COVID-19 pneumonia (Izquierdo JL, 2020) . Despite the fact that SF ratio, a strong predictor of COVID-19 prognosis and mortality Mejía F, 2020) , was slightly higher in hypothyroidism patients, the difference was not clinically relevant (428.6 vs. 423.8, p=0 .034).

The lower requirement of mechanical ventilation had not been observed previously, and it was quite unexpected. It is known that patients with decompensated hypothyroidism may have abnormalities in pulmonary function, muscle myopathy and neuropathy, with respiratory muscle weakness, but these abnormalities improve with treatment (Siafakas NM, 1992; Laroche CM, 1988 Bakshi SS, 2021; van Gerwen M, 2020; Daraei M, 2020; Tsivgoulis G, 2021; Lui DTW, 2021b; Allam MM, 2021) . In the present study, a caliper width of 0.17 was used for the matched analysis. It is considered conservative and restricts the selection of controls which are indeed similar to the cases, as recommended (Austin PC, 2011) . Due to a successful matched-analysis between samples, it is unlikely that age, sex or other underlying diseases have interfered with the results, although patients with hypothyroidism showed a higher prevalence for coronary artery disease and chronic kidney disease. Medications used during hospitalization were also similar in both groups, and, therefore, cannot explain the difference in prognosis as well.

This study has limitations to be addressed. It is a pragmatic study, based on data from chart review. Thyroid disease status was based on patients' information given at hospital admission, so it was not possible to know if the hypothyroidism was compensated or not.

Nevertheless, to the best of our knowledge, the study has the largest sample of COVID-19 patients with hypothyroidism published so far. TSH and thyroid hormone (T4 and T3) levels

were not evaluated during the time of hospitalization and time in the ICU, as the health organizations recommend against testing for thyroid dysfunction during an acute illness, unless it is suspected the acute illness is due to thyroid dysfunction, (den Berghe, 2014; NICE guideline, 2019) and it was not our aim to access the effects of NTIS. The assessment of thyroid hormone levels throughout the course of COVID-19 is still challenging, due to the possibility of overdiagnosis due to abnormal hormone levels during acute systemic disease. It is important to emphasize that these hormonal changes are adaptive processes and cannot be defined as a disease itself.

In this multicenter cohort of Covid-19 in patients, those with underlying hypothyroidism, had similar comorbidities, clinical presentation and laboratory exams than the control group. It was found, nonetheless, that a lower proportion of patients with hypothyroidism required mechanical ventilation, and had a trend of lower in-hospital mortality. Therefore, hypothyroidism does not seem to be associated with a worse prognosis, and should not be considered among the comorbidities that indicate a risk factor for COVID-19 severity.

The study has been conducted by a protocol approved by the National Commission for Research Ethics 15 (CAAE 30350820.5.1001 .0008). Individual informed consent was waived due to the pandemic and to the fact that all data collected was unidentified, gathered through medical records.

Data is available upon reasonable request.

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. 

The sponsors had no role in study design; data collection, management, analysis, and interpretation; writing the manuscript; and deciding to submit it for publication. DNP, LFGS, MMMG, MSM and MCP had full access to all the data in the study and had responsibility for the decision to submit for publication.

Substantial contributions for the conception or design of the manuscript: MSM, DNP,

Substantial contributions for data acquisition, analysis or interpretation: all authors. We also thank all the clinical staff at those hospitals, who cared for the patients, and all undergraduate students who helped with data collection.

The lead authors (DNP, MCP and MSM) affirm that the manuscript is an honest, 

Coordinator of the Institute for Health Technology Assessment (IATS/CNPq). Rua Ramiro Barcelos, 2359. Prédio 21 | Sala

Hospital Risoleta Tolentino Neves

Hospital das Clínicas da Faculdade de Medicina de Botucatu

Hospital de Clínicas de Porto Alegre

Coordinator of the Research Sector of Grupo Hospitalar Conceição

Graduation Program on Evaluation and Production of Technologies for the Brazilian National Health System, Hospital Nossa Senhora da Conceição and Hospital Cristo Redentor

Thyroid disease and covid-19 infection: Case series. Clin Case Rep

Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies

Is there an association between hypothyroidism and COVID 19? : A preliminary report

Thyroid dysfunction in COVID-19 patients

Evaluation of completeness of dengue records: exploratory study of compulsory notices

Thyroid Hormone Levels During Hospital Admission Inform Disease Severity and Mortality in COVID-19 Patients

British Columbia Ministry of Health. Thyroid Function Testing in the Diagnosis and Monitoring of Thyroid Function Disorder. Guidelines and Protocol Advisory Committee

Subacute thyroiditis as a presenting manifestation of COVID-19: a report of an exceedingly rare clinical entity

Possible role of hypothyroidism in the prognosis of COVID-19

Risk factors for cardiovascular disease in subclinical hypothyroidism

Subclinical hypothyroidism, lipid metabolism and cardiovascular disease

COVID-19 and Thyroid Diseases: A Bidirectional Impact

Thyroid function in critically ill patients

Thyroid hormone concentrations in severely or critically ill patients with COVID-19

The relationship between cultural tightness-looseness and COVID-19 cases and deaths: a global analysis

The REDCap consortium: Building an international community of software platform partners

Thyroid dysfunction and kidney disease: An update

Clinical Characteristics and Prognostic Factors for Intensive Care Unit Admission of Patients With COVID-19: Retrospective Study Using Machine Learning and Natural Language Processing

The Effects of Previous Thyroid Disease on the Susceptibility to, Morbidity of, and Mortality Due to COVID-19: A Nationwide Cohort Study in South Korea

Treatment of Thyroid Dysfunction and Serum Lipids: A Systematic Review and Meta-analysis

Hypothyroidism presenting with respiratory muscle weakness

Role of non-thyroidal illness syndrome in predicting adverse outcomes in COVID-19 patients predominantly of mild-to-moderate severity

Thyroid Dysfunction in Relation to Immune Profile, Disease Status

Association of hypothyroidism with acute COVID-19: a systematic review

ABC2-SPH risk score for in-hospital mortality in COVID-19 patients: development, external validation and comparison with other available scores

Brazilian COVID-19 Registry Investigators. Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: Results from the Brazilian COVID-19 registry

Management of thyroid disorders during the COVID-19 outbreak: a position statement from the Thyroid Department of the Brazilian Society of

Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru. PLoS One

National Institute for Health and Care Excellence. Thyroid disease: assessment and management (NG145)

SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives

Comorbidity and its Impact on Patients with COVID-19. SN Compr Clin Med

Sick Euthyroid Syndrome on Presentation of Patients With COVID-19: A Potential Marker for Disease Severity

Clinical, radiological and therapeutic characteristics of patients with COVID-19 in Saudi Arabia

Respiratory muscle strength in hypothyroidism

Asthma does not increase COVID-19 mortality and poor outcomes: A systematic review and meta-analysis

Levothyroxine for the Treatment of Subclinical Hypothyroidism and Cardiovascular Disease. Front Endocrinol (Lausanne)

Kumbul Doğuç D. FABP4 levels in hypothyroidism and its relationship with subclinical atherosclerosis

Hypothyroidism is associated with prolonged COVID-19-induced anosmia: a case-control study

Non-thyroidal illness in the ICU: a syndrome with different faces

Outcomes of Patients With Hypothyroidism and COVID-19: A Retrospective Cohort Study. Front Endocrinol (Lausanne)

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

New Insights toward the Acute Non-Thyroidal Illness Syndrome. Front Endocrinol (Lausanne)

World Health Organization. Diagnostic testing for SARS-CoV-2. Interim guidance. Online

Wilcoxon rank sum test; Fisher's exact test aPTT :activated partial thromboplastin time; AST: aspartate transaminase; ALT: alanine aminotransferase; BNP B-type natriuretic peptide; CPK:creatine phosphokinase; NT-proBNP: N-terminal pro-brain natriuretic peptide

INR: international normalized ratio * Times the reference value

We would like to thank the hospitals which are part of this collaboration, for